ANIX - Anixa Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
72.75M
Enterprise Value 3
67.87M
Trailing P/E
N/A
Forward P/E 1
-4.00
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
290.99
Price/Book (mrq)
12.50
Enterprise Value/Revenue 3
271.48
Enterprise Value/EBITDA 6
-4.98

Trading Information

Stock Price History

Beta (3Y Monthly) 1.28
52-Week Change 3-44.61%
S&P500 52-Week Change 36.42%
52 Week High 36.8600
52 Week Low 33.2500
50-Day Moving Average 33.9691
200-Day Moving Average 34.1653

Share Statistics

Avg Vol (3 month) 375.71k
Avg Vol (10 day) 338.04k
Shares Outstanding 520.1M
Float 19.06M
% Held by Insiders 18.79%
% Held by Institutions 15.64%
Shares Short (Sep 30, 2019) 41.15M
Short Ratio (Sep 30, 2019) 425.74
Short % of Float (Sep 30, 2019) 46.53%
Short % of Shares Outstanding (Sep 30, 2019) 45.68%
Shares Short (prior month Aug 30, 2019) 41.22M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/1
Last Split Date 3Oct 18, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Oct 31, 2018
Most Recent Quarter (mrq)Jul 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-5,666.94%

Management Effectiveness

Return on Assets (ttm)-125.28%
Return on Equity (ttm)-261.16%

Income Statement

Revenue (ttm)250k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)344.09k
EBITDA -13.63M
Net Income Avi to Common (ttm)-14.86M
Diluted EPS (ttm)-0.7660
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.5M
Total Cash Per Share (mrq)0.32
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.59
Book Value Per Share (mrq)0.29

Cash Flow Statement

Operating Cash Flow (ttm)-4.43M
Levered Free Cash Flow (ttm)635.44k